Related Experiment Video
Updated: Aug 23, 2026

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
Published on: April 16, 2012
Toward gene therapy for human CD3 deficiencies
A Pacheco-Castro1, J M Martín-Fernández, R Millán
1Inmunología, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.
Abstract:
The CD3 subunits of the T cell receptor-CD3 complex (TCR-CD3) help to regulate surface TCR-CD3 expression, and participate in signal transduction leading to intrathymic selection and peripheral antigen recognition by T lymphocytes. Humans who lack individual CD3 chains show impairments in the expression and activation-induced downregulation of TCR-CD3, and the defective immune responses that result may be lethal. We have investigated delivery of a normal CD3 chain to treat disorders of this type. Retroviral transduction of CD3gamma into CD3gamma-deficient peripheral blood T lymphocytes from two unrelated patients selectively corrected the observed TCR-CD3 expression and downregulation defects, but unexpectedly seemed to cause adverse effects that can be explained by an autoreactive recognition mechanism. These data support the feasibility of gene therapy for human CD3 deficiencies, but also suggest that gene transfer into postthymic lymphocytes carrying mutations on T cell recognition or activation pathways may disrupt their intrathymic calibration and become harmful to the host.
Insights
Gene therapy using CD3gamma corrected T cell receptor defects in patients with CD3 deficiencies. However, this approach may cause harmful autoreactivity by disrupting T cell calibration.
Area of Science:
- Immunology
- Molecular Biology
- Gene Therapy
Background:
- The T cell receptor-CD3 complex (TCR-CD3) is crucial for T lymphocyte function, regulating surface expression and signal transduction.
- Deficiencies in CD3 chains lead to severe immune impairments, potentially causing lethal outcomes.
Purpose of the Study:
- To investigate the feasibility of gene therapy for treating human CD3 deficiencies.
- To assess the efficacy and potential adverse effects of delivering a functional CD3 chain.
Main Methods:
- Retroviral transduction of CD3gamma into peripheral blood T lymphocytes from CD3gamma-deficient patients.
- Analysis of TCR-CD3 expression and activation-induced downregulation post-transduction.
Main Results:
- Gene transfer selectively corrected TCR-CD3 expression and downregulation defects.
- Unexpected adverse effects were observed, suggesting an autoreactive recognition mechanism.
Conclusions:
- Gene therapy is a feasible approach for human CD3 deficiencies.
- Gene transfer into postthymic lymphocytes may disrupt intrathymic calibration, leading to harmful autoreactivity.
Related Concept Videos
Gene Therapy
Tumor Immunotherapy

